Andrew Chen

1.7k total citations
29 papers, 1.1k citations indexed

About

Andrew Chen is a scholar working on Molecular Biology, Genetics and Immunology. According to data from OpenAlex, Andrew Chen has authored 29 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Molecular Biology, 11 papers in Genetics and 6 papers in Immunology. Recurrent topics in Andrew Chen's work include Virus-based gene therapy research (8 papers), CAR-T cell therapy research (5 papers) and Extracellular vesicles in disease (4 papers). Andrew Chen is often cited by papers focused on Virus-based gene therapy research (8 papers), CAR-T cell therapy research (5 papers) and Extracellular vesicles in disease (4 papers). Andrew Chen collaborates with scholars based in United States, Canada and France. Andrew Chen's co-authors include Nathan D. Montgomery, Arie P. Otte, Della Yee, Sundeep Kalantry, Terry Magnuson, Stormy J. Chamberlain, Yumei Cao, Yihai Cao, Donald J. Davidson and Miguel Llinás and has published in prestigious journals such as New England Journal of Medicine, Journal of Biological Chemistry and SHILAP Revista de lepidopterología.

In The Last Decade

Andrew Chen

26 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Andrew Chen United States 13 788 231 196 155 133 29 1.1k
Guang‐Jer Wu United States 23 865 1.1× 206 0.9× 128 0.7× 262 1.7× 109 0.8× 48 1.3k
Peter Bringmann Germany 26 1.5k 1.9× 267 1.2× 251 1.3× 88 0.6× 121 0.9× 44 2.0k
Mary S. Rosendahl United States 18 604 0.8× 109 0.5× 124 0.6× 227 1.5× 209 1.6× 27 1.2k
S. Shin United States 12 679 0.9× 360 1.6× 162 0.8× 250 1.6× 133 1.0× 15 1.3k
Angela Holder United Kingdom 16 361 0.5× 172 0.7× 87 0.4× 91 0.6× 171 1.3× 35 919
Reinhild Kappelhoff Canada 17 492 0.6× 161 0.7× 441 2.3× 411 2.7× 145 1.1× 25 1.3k
Johannes Dodt Germany 24 601 0.8× 392 1.7× 276 1.4× 329 2.1× 138 1.0× 46 1.8k
Erhard Kopetzki Germany 21 574 0.7× 77 0.3× 121 0.6× 120 0.8× 98 0.7× 29 1.1k
Annie Molla France 21 977 1.2× 155 0.7× 91 0.5× 241 1.6× 177 1.3× 56 1.4k
Mireille Vankemmelbeke United Kingdom 19 448 0.6× 268 1.2× 177 0.9× 133 0.9× 138 1.0× 42 937

Countries citing papers authored by Andrew Chen

Since Specialization
Citations

This map shows the geographic impact of Andrew Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrew Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrew Chen more than expected).

Fields of papers citing papers by Andrew Chen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andrew Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrew Chen. The network helps show where Andrew Chen may publish in the future.

Co-authorship network of co-authors of Andrew Chen

This figure shows the co-authorship network connecting the top 25 collaborators of Andrew Chen. A scholar is included among the top collaborators of Andrew Chen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andrew Chen. Andrew Chen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
3.
Qiu, Yuhan, Andrew Chen, Rebecca Yu, et al.. (2025). Insulin Resistance Increases TNBC Aggressiveness and Brain Metastasis via Adipocyte-Derived Exosomes. Molecular Cancer Research. 23(6). 567–578. 2 indexed citations
4.
5.
Wong, Boaz, Daniel Serrano, Zaid Taha, et al.. (2023). Pevonedistat, a first-in-class NEDD8-activating enzyme inhibitor, sensitizes cancer cells to VSVΔ51 oncolytic virotherapy. Molecular Therapy. 31(11). 3176–3192. 11 indexed citations
6.
Taha, Zaid, et al.. (2023). Unlocking the potential of dimethyl fumarate: enhancing oncolytic HSV-1 efficacy for wider cancer applications. Frontiers in Immunology. 14. 1332929–1332929. 4 indexed citations
7.
Taha, Zaid, Oliver Varette, Andrew Chen, et al.. (2022). Vanadyl sulfate-enhanced oncolytic virus immunotherapy mediates the antitumor immune response by upregulating the secretion of pro-inflammatory cytokines and chemokines. Frontiers in Immunology. 13. 1032356–1032356. 6 indexed citations
8.
Lovergne, Lila, Aris Polyzos, Andrew Chen, et al.. (2021). An infrared spectral biomarker accurately predicts neurodegenerative disease class in the absence of overt symptoms. Scientific Reports. 11(1). 15598–15598. 11 indexed citations
9.
Arulanandam, Rozanne, Zaid Taha, Vanessa da Silva Garcia, et al.. (2020). The strategic combination of trastuzumab emtansine with oncolytic rhabdoviruses leads to therapeutic synergy. Communications Biology. 3(1). 254–254. 11 indexed citations
10.
Tzelepis, Fanny, Silvia Beatriz Boscardin, Christiano Tanese de Souza, et al.. (2020). Oncolytic Rhabdovirus Vaccine Boosts Chimeric Anti-DEC205 Priming for Effective Cancer Immunotherapy. Molecular Therapy — Oncolytics. 19. 240–252. 2 indexed citations
11.
Selman, Mohammed, Ramya Krishnan, Larissa A. Pikor, et al.. (2018). Dimethyl fumarate potentiates oncolytic virotherapy through NF-κB inhibition. Science Translational Medicine. 10(425). 44 indexed citations
12.
Krishnan, Ramya, Andrew Macklin, Mohammed Selman, et al.. (2016). First-in-class small molecule potentiators of cancer virotherapy. Scientific Reports. 6(1). 26786–26786. 24 indexed citations
13.
Thompson, Jess L., et al.. (2014). Heme oxygenase derived carbon monoxide and iron mediated plasmatic hypercoagulability in a patient with calcific mitral valve disease. Journal of Thrombosis and Thrombolysis. 39(4). 532–535. 2 indexed citations
14.
Huang, Ruili, et al.. (2011). Two High Throughput Screen Assays for Measurement of TNF-α in THP-1 Cells. PubMed. 5. 21–29. 24 indexed citations
15.
Yang, Ming, et al.. (2011). Matrix Metalloproteinase Activity Causes VEGFR‐2 Cleavage and Microvascular Rarefaction in Rat Mesentery. Microcirculation. 18(3). 228–237. 18 indexed citations
16.
Watson, John T., et al.. (2010). Distinct functionalities of bone morphogenetic protein antagonists during fracture healing in mice. Journal of Anatomy. 216(5). 625–630. 28 indexed citations
17.
Migone, Thi-Sau, G. Mani Subramanian, John Zhong, et al.. (2009). Raxibacumab for the Treatment of Inhalational Anthrax. New England Journal of Medicine. 361(2). 135–144. 202 indexed citations
18.
Montgomery, Nathan D., Della Yee, Andrew Chen, et al.. (2005). The Murine Polycomb Group Protein Eed Is Required for Global Histone H3 Lysine-27 Methylation. Current Biology. 15(10). 942–947. 280 indexed citations
19.
Johnson, Anna E., et al.. (2002). AUA as a Translation Initiation Site In Vitro for the Human Transcription Factor Sp3. BMB Reports. 35(3). 273–282. 8 indexed citations
20.
Cao, Yihai, Andrew Chen, Seong Soo An, et al.. (1997). Kringle 5 of Plasminogen is a Novel Inhibitor of Endothelial Cell Growth. Journal of Biological Chemistry. 272(36). 22924–22928. 244 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Guang‐Jer Wu Breakdown of academic impact, for papers by Peter Bringmann Breakdown of academic impact, for papers by Mary S. Rosendahl Breakdown of academic impact, for papers by S. Shin Breakdown of academic impact, for papers by Angela Holder Breakdown of academic impact, for papers by Reinhild Kappelhoff Breakdown of academic impact, for papers by Johannes Dodt Breakdown of academic impact, for papers by Erhard Kopetzki Breakdown of academic impact, for papers by Annie Molla Breakdown of academic impact, for papers by Mireille Vankemmelbeke
Rankless by CCL
2026